EU lawmakers have been locked in intense negotiations for months on loosening rules on the use of new genetic technologies in ...

Scientists identified cellular metabolism and energy signaling as a central factor connecting genetic and environmental ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

A Bay Area biochemist has launched a new company to further research on gene editing on human embryos. Lucas Harrington said the research will focus on using the technology to prevent genetic disease ...

Discusses Pipeline Advancements in Paccal Vet and Cantrixil and Strategic Capital Raise November 24, 2025 9:00 AM ...

Nobel Prize- winning American scientist James Dewey Watson, the man who unravelled the ‘secret of life’, passed away on November 6, 2025. Watson, who is widely remembered as the Godfather of ...

Brain organoids are revolutionising research, but their growing complexity raises unsettling ethical questions.

After more than 50 years of research, scientists still don't know exactly what causes autism. But the data make clear that ...

Judge Pauline Newman has served with distinction on the U.S. Court of Appeals for the Federal Circuit since her appointment by President Ronald Reagan in 1984. Her career has been marked by a ...

On November 25, 2025, Sarepta Therapeutics filed two petitions for inter partes review (“IPR”) challenging Genzyme’s patents relating to ...

The U.S. Patent and Trademark Office issued new guidelines on Wednesday outlining when inventions created with the help of ...

On November 18, 2025, ToolGen, Inc. (“ToolGen”) filed a complaint (“Complaint”) in the District of Massachusetts alleging infringement of its ...